1 week ago
Can-Fite BioPharma (CANF) Stock Soars 107% on Positive Pancreatic Cancer Safety Data
Can-Fite BioPharma (CANF) stock jumped 107% after namodenoson successfully completed Phase 2a safety testing in 20 pancreatic cancer patients.
The post Can-Fite BioPharma (CANF) Stock Soars 107% on Positive Pancreatic Cancer Safety Data appeared first on Blockonomi.
Source: Blockonomi →Related News
- 11 hours ago
Qualcomm (QCOM) Stock: CFO Dumps Over $330K While Shares Hover Near Annual Lows
- 11 hours ago
5 Undervalued AI Stocks for 2026: Oracle (ORCL), AMD, Micron (MU), TSMC and Dell...
- 12 hours ago
Market Preview: Federal Reserve Meeting, Oil Surge Past $100, and Micron (MU) Ea...
- 14 hours ago
Nvidia (NVDA) vs AMD: The Ultimate AI Stock Showdown for 2025
- 14 hours ago
Ciena (CIEN) Stock Named Top Pick by TD Cowen with $425 Price Target